Patents by Inventor Satish Kumar Jain

Satish Kumar Jain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
    Publication number: 20160089353
    Abstract: The present invention provides an oral pharmaceutical composition of isotretinoin having enhanced bioavailability. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Application
    Filed: December 3, 2015
    Publication date: March 31, 2016
    Inventors: Rajesh RAO, Anuj Kumar FANDA, Satish Kumar JAIN, Romi Barat SINGH
  • PHARMACEUTICAL COMPOSITION OF DOXYCYCLINE WITH REDUCED FOOD EFFECT
    Publication number: 20160082021
    Abstract: The present invention relates to a once daily tablet comprising doxycycline at sub-antibiotic dose and one or more pharmaceutically acceptable excipients, wherein the tablet exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline tablet with or without food. A process of preparing the tablet is also provided.
    Type: Application
    Filed: December 4, 2015
    Publication date: March 24, 2016
    Inventors: Ravish Kumar SHARMA, Pulak Kumar METIA, Ravinder SINGH, Rajesh Srikrishan SHEAR, Anuj Kumar FANDA, Satish Kumar JAIN, Romi Barat SINGH, Swarna PAPPU, Prabhakar KONATHAM, Pruthvipathy KATIKANENI, Dileep JAMI
  • ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
    Publication number: 20160081964
    Abstract: The present invention provides an oral pharmaceutical composition of isotretinoin with reduced food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Application
    Filed: December 3, 2015
    Publication date: March 24, 2016
    Inventors: Rajesh RAO, Anuj Kumar FANDA, Satish Kumar JAIN, Romi Barat SINGH
  • Pharmaceutical composition of doxycycline
    Patent number: 9132092
    Abstract: The present invention relates to a pharmaceutical composition comprising (i) 50% to 99% of doxycycline as an immediate-release portion; (ii) 1% to 50% of doxycycline as a controlled-release portion; and (iii) one or more pharmaceutically acceptable excipients; wherein the pharmaceutical composition provides a total daily dosage of 40 mg when administered once daily. It also relates to process for preparation of the pharmaceutical composition and its use for treating rosacea.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: September 15, 2015
    Assignee: RANBAXY LABORATORIES LIMITED
    Inventors: Ravish Kumar Sharma, Pulak Kumar Metia, Ravinder Singh, Rajesh Srikrishan Shear, Anuj Kumar Fanda, Satish Kumar Jain, Romi Barat Singh, Swarna Pappu, Prabhakar Konatham, Pruthvipathy Katikaneni
  • STABLE ORAL PHARMACEUTICAL COMPOSITION OF SOLIFENACIN
    Publication number: 20150150814
    Abstract: The present invention relates to stable oral pharmaceutical compositions comprising solifenacin or a salt thereof prepared by a double compaction process, wherein the amorphous content of solifenacin or a salt thereof in the composition is not less than 80% by weight. It further relates to a method of treating or preventing overactive bladder syndrome by administering said pharmaceutical compositions.
    Type: Application
    Filed: December 1, 2014
    Publication date: June 4, 2015
    Inventors: Rajesh Srikrishan SHEAR, Girish MITTAL, Sumit MADAN, Satish Kumar JAIN, Romi Barat SINGH
  • Lanthanum composition
    Patent number: 8974824
    Abstract: The present invention discloses stable, solid oral pharmaceutical composition comprising Lanthanum carbonate having more than 6 molecules of water per molecule of lanthanum carbonate and pharmaceutically acceptable carriers or diluents, wherein said carrier or diluent excludes monosaccharide/s or disaccharide/s, such that the composition has comparable in-vitro dissolution profile similar to that of FOSRENOL®. Also disclosed is a wet granulation process for making the same.
    Type: Grant
    Filed: March 24, 2009
    Date of Patent: March 10, 2015
    Assignee: Mylan Laboratories Ltd.
    Inventors: Nagaraj Amminabavi, Indu Bhushan, Satish Kumar Jain, Subhash Gore, Gnanadeva Chalapathy Gudipati, Balakrishnan Chinnu, Subramanian Iyer, Manoj P Kumar, Rajesh S Gupta